{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:53:12Z","timestamp":1781844792964,"version":"3.54.5"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Endoscopic papillectomy (EP) is the first-line treatment for ampullary tumors, and radiofrequency ablation (RFA) as an alternative or adjunctive treatment. This study systematically analyzed EP\u2019s clinical outcomes and evaluated the feasibility and safety of a sequential RFA-first strategy for complex ampullary tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed 132 patients treated with EP or RFA at Shenzhen People\u2019s Hospital from April 2018 to August 2024. Categorical variables were presented as frequencies (percentages), and continuous variables as mean \u00b1 Standard Deviation (SD). Binary logistic regression analyzed risk factors. Propensity score matching and analysis of variance (ANOVA) compared adverse events between treatments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Initially, 123 of 132 patients underwent EP, while 9 received RFA as the initial treatment due to tumors &amp;gt;3\u202fcm, peri-diverticular lesions, and intraductal invasive lesions. The technical success rate was 100%, and the overall short-term clinical success rate was 96.6%. Adverse events occurred in 20.5% of the patients. Tumor size was identified as a significant risk factor for adverse events such as postprocedural pancreatitis (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.03), intraprocedural bleeding (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001), and postprocedural bleeding (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.024). The short-term clinical success rate of the RFA group was 91.7%, while adverse events were observed in 16.7% of the patients. Significantly, our findings revealed a statistically no significant difference in adverse events between the RFA and non-RFA groups (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.719).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>An upfront RFA strategy followed by staged EP or additional RFA may be a potentially feasible and safe method to reduce adverse events in select patients with complex ampullary tumors. However, long-term efficacy and late complication rates require further evaluation with extended follow-up.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1835891","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:29:19Z","timestamp":1781843359000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A sequential strategy of upfront radiofrequency ablation followed by endoscopic papillectomy for complex ampullary tumors"],"prefix":"10.3389","volume":"13","author":[{"given":"Benhua","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Shenzhen People\u2019s Hospital, The Second Clinical Medical College, Jinan University","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisheng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Shenzhen People\u2019s Hospital, The Second Clinical Medical College, Jinan University","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbiao","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Shenzhen People\u2019s Hospital, The Second Clinical Medical College, Jinan University","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3238\/arztebl.m2023.0195","article-title":"The diagnosis and treatment of ampullary carcinoma","volume":"120","author":"Walter","year":"2023","journal-title":"Dtsch Arztebl Int"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"15134","DOI":"10.1038\/s41598-022-19439-3","article-title":"Advantage of endoscopic papillectomy for ampullary tumors as an alternative treatment for pancreatoduodenectomy","volume":"12","author":"Abe","year":"2022","journal-title":"Sci Rep"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.giec.2022.01.005","article-title":"Endoscopic Papillectomy","volume":"32","author":"Campos","year":"2022","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.hbpd.2024.02.001","article-title":"Bleeding after endoscopic papillectomy and its risk factors: a single center experience of 196 cases","volume":"23","author":"Choi","year":"2024","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.gie.2021.04.009","article-title":"Expert consensus on endoscopic papillectomy using a Delphi process","volume":"94","author":"Fritzsche","year":"2021","journal-title":"Gastrointest Endosc"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"6259","DOI":"10.1007\/s00464-020-08126-x","article-title":"Endoscopic papillectomy; a retrospective international multicenter cohort study with long-term follow-up","volume":"35","author":"Fritzsche","year":"2021","journal-title":"Surg Endosc"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1177\/17562848221090820","article-title":"Efficacy and safety of endoscopic papillectomy: a multicenter, retrospective, cohort study on 227 patients","volume":"15","author":"Gondran","year":"2022","journal-title":"Ther Adv Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1016\/j.dld.2024.04.037","article-title":"Recurrence rate and management after endoscopic papillectomy in a tertiary referral center","volume":"56","author":"Dioscoridi","year":"2024","journal-title":"Dig Liver Dis"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1007\/s00464-023-10567-z","article-title":"The timing of recurrence after endoscopic papillectomy","volume":"38","author":"Han","year":"2024","journal-title":"Surg Endosc"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"E440","DOI":"10.1055\/a-2226-0928","article-title":"Radiofrequency ablation for ampullary neoplasia with intraductal extension after endoscopic papillectomy: systematic review and meta-analysis","volume":"12","author":"Landim","year":"2024","journal-title":"Endosc Int Open"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/den.13298","article-title":"Endoscopic radiofrequency biliary ablation treatment: a comprehensive review","volume":"31","author":"Larghi","year":"2019","journal-title":"Dig Endosc"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.gie.2018.04.2332","article-title":"Efficacy and safety of endobiliary radiofrequency ablation for the eradication of residual neoplasia after endoscopic papillectomy: a multicenter prospective study","volume":"88","author":"Camus","year":"2018","journal-title":"Gastrointest Endosc"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"638","DOI":"10.5009\/gnl220201","article-title":"Long-term outcomes of endoscopic intraductal radiofrequency ablation for ampullary adenoma with intraductal extension after endoscopic snare papillectomy","volume":"17","author":"Cho","year":"2023","journal-title":"Gut Liver"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"E141","DOI":"10.1055\/a-1408-1572","article-title":"Double-wire-guided reopenable-clip closure of a mucosal defect after endoscopic papillectomy","volume":"54","author":"Nomura","year":"2022","journal-title":"Endoscopy"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1055\/a-1737-3843","article-title":"Effect of prophylactic endoscopic clipping for prevention of delayed bleeding after endoscopic papillectomy for ampullary neoplasm: a multicenter randomized trial","volume":"54","author":"Park","year":"2022","journal-title":"Endoscopy"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"E185","DOI":"10.1055\/a-1960-3253","article-title":"Bile duct radiofrequency ablation for a residual adenoma after endoscopic papillectomy","volume":"55","author":"Takeshita","year":"2023","journal-title":"Endoscopy"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1055\/a-1397-3198","article-title":"Endoscopic management of ampullary tumors: European Society of Gastrointestinal Endoscopy (ESGE) guideline","volume":"53","author":"Vanbiervliet","year":"2021","journal-title":"Endoscopy"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.gie.2016.12.022","article-title":"Radiofrequency ablation for intraductal extension of ampullary neoplasms: are we ready to feel the burn?","volume":"86","author":"Watson","year":"2017","journal-title":"Gastrointest Endosc"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1177\/2050640618817215","article-title":"Combined excision and ablation of ampullary tumors with biliary or pancreatic intraductal extension is effective even in malignant neoplasms","volume":"7","author":"P\u00e9rez-Cuadrado-Robles","year":"2019","journal-title":"United European Gastroenterol J"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"E749","DOI":"10.1055\/a-1387-7880","article-title":"Radiofrequency ablation for intraductal extension of ampullary adenomatous lesions: proposal for a standardized protocol","volume":"9","author":"Tringali","year":"2021","journal-title":"Endosc Int Open"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1080\/00365521.2022.2085058","article-title":"Analysis of risk factors for post-endoscopic papillectomy bleeding","volume":"57","author":"Cui","year":"2022","journal-title":"Scand J Gastroenterol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"659","DOI":"10.5946\/ce.2019.171","article-title":"Management of remnant or recurrent lesions after endoscopic papillectomy","volume":"53","author":"Yasuda","year":"2020","journal-title":"Clin Endosc"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.3748\/wjg.v28.i17.1845","article-title":"Clinical outcomes of endoscopic papillectomy of ampullary adenoma: a multi-center study","volume":"28","author":"Choi","year":"2022","journal-title":"World J Gastroenterol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"307","DOI":"10.5009\/gnl20043","article-title":"The safety of radiofrequency ablation using a novel temperature-controlled probe for the treatment of residual intraductal lesions after endoscopic papillectomy","volume":"15","author":"Choi","year":"2021","journal-title":"Gut Liver"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.gie.2016.10.007","article-title":"Endoscopic papillectomy for adenoma: to inject or not to inject? That is no longer the question","volume":"85","author":"Carr-Locke","year":"2017","journal-title":"Gastrointest Endosc"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.gie.2016.08.013","article-title":"A prospective multicenter study of submucosal injection to improve endoscopic snare papillectomy for ampullary adenoma","volume":"85","author":"Hyun","year":"2017","journal-title":"Gastrointest Endosc"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"706","DOI":"10.5946\/ce.2020.208","article-title":"Efficacy of hypertonic saline-epinephrine local injection around the anal side before endoscopic papillectomy for ampullary tumors","volume":"54","author":"Okano","year":"2021","journal-title":"Clin Endosc"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"627","DOI":"10.5946\/ce.2021.173","article-title":"Submucosal epinephrine injection before endoscopic papillectomy: less is more?","volume":"54","author":"van Wanrooij","year":"2021","journal-title":"Clin Endosc"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"goad050","DOI":"10.1093\/gastro\/goad050","article-title":"Long-term follow-up of endoscopic papillectomy and the value of preventive pancreatic stent placement (with videos)","volume":"11","author":"Wang","year":"2023","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/den.14233","article-title":"Clinical practice guidelines for endoscopic papillectomy","volume":"34","author":"Itoi","year":"2022","journal-title":"Dig Endosc"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1111\/jgh.15462","article-title":"Long-term outcomes of endoscopic papillectomy for early-stage cancer in duodenal ampullary adenoma: comparison to surgical treatment","volume":"36","author":"Hwang","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"151","DOI":"10.5009\/gnl210080","article-title":"Intraductal radiofrequency ablation for residual adenoma after endoscopic papillectomy: an additional treatment modality expected to be safe and effective","volume":"15","author":"Cho","year":"2021","journal-title":"Gut Liver"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1055\/a-1096-1592","article-title":"Successful intraductal radiofrequency ablation of residual adenoma tissue following endoscopic papillectomy","volume":"58","author":"Gereitzig","year":"2020","journal-title":"Z Gastroenterol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1159\/000513970","article-title":"Role of intraductal RFA: a novel tool in the palliative care of Perihilar cholangiocarcinoma","volume":"37","author":"Weism\u00fcller","year":"2021","journal-title":"Visc Med"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1835891\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:29:21Z","timestamp":1781843361000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1835891\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":34,"alternative-id":["10.3389\/fmed.2026.1835891"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1835891","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"article-number":"1835891"}}